GSK’s top scientist to quit, become CEO of anti-ageing start-up
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
Investment
VitriVax: one-shot Covid-19 vaccines to improve global access
Are competition authorities tightening the rules on pharma M&A?
Engine Biosciences raises $43m in series A for AI drug discovery
Science park merger creates UK’s largest life sciences ecosystem
Kazakhstan pursues diversification agenda
FDI drivers and political stability
Will blockchain reshape trade and investment?
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
